Literature DB >> 16008621

Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan.

P R Hsueh1, S P Tseng, L J Teng, S W Ho.   

Abstract

This study evaluated the clinical and microbiological characteristics of 16 patients who were colonised or infected with 26 isolates of pan-drug-resistant Pseudomonas aeruginosa (PDRPA; intermediately-resistant or resistant to all cephalosporins, piperacillin-tazobactam, aztreonam, carbapenems, ciprofloxacin and aminoglycosides) in a university hospital during 1999-2002. All the isolates had colistin MICs < or = 4 mg/L, 19 (73%) isolates had bla(VIM-3), and 25 (96%) isolates had class I integrons (intI). Time-kill studies for two PDRPA blood isolates demonstrated synergism for cefepime-amikacin after 24 h. Pulsed-field gel electrophoresis analysis of the isolates revealed a polyclonal nature (12 pulsotypes), although clonal dissemination of PDRPA isolates among these patients was also present.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16008621     DOI: 10.1111/j.1469-0691.2005.01196.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  16 in total

1.  Tn6001, a transposon-like element containing the blaVIM-3-harboring integron In450.

Authors:  Sung-Pin Tseng; Po-Ren Hsueh; Jui-Chang Tsai; Lee-Jene Teng
Journal:  Antimicrob Agents Chemother       Date:  2007-09-10       Impact factor: 5.191

2.  Interaction of colistin and colistin methanesulfonate with liposomes: colloidal aspects and implications for formulation.

Authors:  Stephanie J Wallace; Jian Li; Roger L Nation; Richard J Prankerd; Ben J Boyd
Journal:  J Pharm Sci       Date:  2012-05-23       Impact factor: 3.534

Review 3.  Alternative folding pathways of the major porin OprF of Pseudomonas aeruginosa.

Authors:  Etsuko Sugawara; Keiji Nagano; Hiroshi Nikaido
Journal:  FEBS J       Date:  2012-02-10       Impact factor: 5.542

4.  Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital.

Authors:  L Vettoretti; N Floret; D Hocquet; B Dehecq; P Plésiat; D Talon; X Bertrand
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-07       Impact factor: 3.267

5.  Epinecidin-1 has immunomodulatory effects, facilitating its therapeutic use in a mouse model of Pseudomonas aeruginosa sepsis.

Authors:  Chieh-Yu Pan; Jian-Chyi Chen; Jenn-Feng Sheen; Tai-Lang Lin; Jyh-Yih Chen
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

6.  Factors affecting the folding of Pseudomonas aeruginosa OprF porin into the one-domain open conformer.

Authors:  Etsuko Sugawara; Keiji Nagano; Hiroshi Nikaido
Journal:  MBio       Date:  2010-10-19       Impact factor: 7.867

7.  A large sustained endemic outbreak of multiresistant Pseudomonas aeruginosa: a new epidemiological scenario for nosocomial acquisition.

Authors:  Cristina Suarez; Carmen Peña; Olga Arch; M Angeles Dominguez; Fe Tubau; Carlos Juan; Laura Gavaldá; Mercedes Sora; Antonio Oliver; Miquel Pujol; Javier Ariza
Journal:  BMC Infect Dis       Date:  2011-10-13       Impact factor: 3.090

8.  Burn Patients Infected With Metallo-Beta-Lactamase-Producing Pseudomonas aeruginosa: Multidrug-Resistant Strains.

Authors:  Mojtaba Anvarinejad; Aziz Japoni; Noroddin Rafaatpour; Jalal Mardaneh; Pejman Abbasi; Maneli Amin Shahidi; Mohammad Ali Dehyadegari; Ebrahim Alipour
Journal:  Arch Trauma Res       Date:  2014-06-01

9.  Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan.

Authors:  Sung-Pin Tseng; Jui-Chang Tsai; Lee-Jene Teng; Po-Ren Hsueh
Journal:  J Antimicrob Chemother       Date:  2009-09-22       Impact factor: 5.790

10.  Phylogenetic Distribution of CRISPR-Cas Systems in Antibiotic-Resistant Pseudomonas aeruginosa.

Authors:  Alex van Belkum; Leah B Soriaga; Matthew C LaFave; Srividya Akella; Jean-Baptiste Veyrieras; E Magda Barbu; Dee Shortridge; Bernadette Blanc; Gregory Hannum; Gilles Zambardi; Kristofer Miller; Mark C Enright; Nathalie Mugnier; Daniel Brami; Stéphane Schicklin; Martina Felderman; Ariel S Schwartz; Toby H Richardson; Todd C Peterson; Bolyn Hubby; Kyle C Cady
Journal:  mBio       Date:  2015-11-24       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.